As neurological conditions expose the limits of traditional clinical endpoints, Europe’s regulators are being pushed to ...
The European Medicines Agency (EMA) plans to release a reflection paper regarding when external controls can be used to generate evidence to support regulatory decisions on drug approvals. @The agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback